Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls

Pharmacopsychiatry

Volumn 44, Issue 4, 2011, Pages 129-134

  Sommer, M ^a   Braumann, M ^b   Althoff, T ^a   Backhaus, J ^c   Kordon, A ^c   Junghanns, K ^c   Ehrenthal, D ^c   Bartmann, U ^a   Hohagen, F ^c   Broocks, A ^a,d  

^a HELIOS KLINIKEN SCHWERIN   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d NONE   (Germany)

Author keywords

exercise; noradrenaline; psychosocial stress; yohimbine

Indexed keywords

HYDROCORTISONE; PLACEBO; YOHIMBINE;

ADULT; AEROBIC FITNESS; ANXIETY; ARTICLE; ATHLETE; BICYCLE ERGOMETRY; BLOOD PRESSURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDURANCE TRAINING; FITNESS; FUNCTION TEST; HEART RATE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOSOCIAL STRESS TEST; RANDOMIZED CONTROLLED TRIAL; SOCIAL STRESS;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADULT; ANXIETY; ATHLETES; BEHAVIOR; BLOOD PRESSURE; DOUBLE-BLIND METHOD; GERMANY; HEART RATE; HUMANS; HYDROCORTISONE; INTERPERSONAL RELATIONS; MALE; NEUROSECRETORY SYSTEMS; PHYSICAL ENDURANCE; PHYSICAL FITNESS; PSYCHIATRIC STATUS RATING SCALES; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; YOHIMBINE;

EID: 79959409946     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1277166     Document Type: Article

References (38)

1. Farmer ME, Locke BZ, Moscicki EK et al,. Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1988 128 1340-1351 (Pubitemid 19015506)
2. Mead GE, Morley W, Campbell P et al,. Exercise for depression. Cochrane Database Syst Rev 2009 CD004366
3. Doyne EJ, Ossip-Klein DJ, Bowman ED et al,. Running versus weight lifting in the treatment of depression. J Consult Clin Psychol 1987 55 748-754
4. Martinsen EW, Hoffart A, Solberg O. Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: a randomized trial. Compr Psychiatry 1989 30 324-331 (Pubitemid 19177209)
5. Babyak M, Blumenthal JA, Herman S et al,. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 2000 62 633-638
6. Blumenthal JA, Babyak MA, Moore KA et al,. Effects of exercise training on older patients with major depression. Arch Intern Med 1999 159 2349-2356 (Pubitemid 29501535)
7. Martinsen EW, Medhus A, Sandvik L. Effects of aerobic exercise on depression: a controlled study. Br Med J (Clin Res Ed) 1985 291 109 (Pubitemid 15068726)
8. Blumenthal JA, Babyak MA, Doraiswamy PM et al,. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007 69 587-596 (Pubitemid 47469807)
9. Broocks A, Bandelow B, Pekrun G et al,. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998 155 603-609 (Pubitemid 28225398)
10. Huether G, Doering S, Ruger U et al,. The stress-reaction process and the adaptive modification and reorganization of neuronal networks. Psychiatry Res 1999 87 83-95 (Pubitemid 29421702)
11. Sullivan GM, Coplan JD, Kent JM et al,. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 1999 46 1205-1218 (Pubitemid 30114438)
12. Redmond DE Jr. The possible role of locus coeruleus noradrenergic activity in anxiety-panic. Clin Neuropharmacol 1986 9 40-42
13. Redmond DE Jr, Huang YH. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 1979 25 2149-2162 (Pubitemid 10145870)
14. Winter JC, Rabin RA. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 1992 263 682-689
15. Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur Arch Psychiatry Clin Neurosci 1992 241 345-351
16. Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. Eur Arch Psychiatry Clin Neurosci 1992 241 337-344
17. Charney DS, Heninger GR. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1986 43 1042-1054 (Pubitemid 17173225)
18. Charney DS, Woods SW, Goodman WK et al,. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987 144 1030-1036 (Pubitemid 17143562)
19. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003 121 185-196 (Pubitemid 37500988)
20. Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 1999 46 1219-1233 (Pubitemid 30114439)
21. Broocks A, Meyer T, George A et al,. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Neuropsychopharmacology 1999 20 150-161 (Pubitemid 29010374)
22. Post RM, Kotin J, Goodwin FK et al,. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 1973 130 67-72
23. Beckmann H, Ebert MH, Post R et al,. Effect of moderate exercise on urinary MHPG in depressed patients. Pharmakopsychiatr Neuropsychopharmakol 1979 12 351-356 (Pubitemid 10237677)
24. Broocks A, Liu J, Pirke KM. Semistarvation-induced hyperactivity compensates for decreased norepinephrine and dopamine turnover in the mediobasal hypothalamus of the rat. J Neural Transm Gen Sect 1990 79 113-124 (Pubitemid 20002907)
25. Broocks A, Schweiger U, Pirke KM. The influence of semistarvation-induced hyperactivity on hypothalamic serotonin metabolism. Physiol Behav 1991 50 385-388
26. Dishman RK. Brain monoamines, exercise, and behavioral stress: animal models. Med Sci Sports Exerc 1997 29 63-74 (Pubitemid 27043141)
27. Dunn AL. Getting started a review of physical activity adoption studies. Br J Sports Med 1996 30 193-199 (Pubitemid 26326572)
28. Morgan ME, Yamamoto BK, Freed CR. Unilateral activation of caudate tyrosine hydroxylase during voluntary circling behavior. J Neurochem 1984 43 737-741 (Pubitemid 14065457)
29. Dishman RK, Renner KJ, Youngstedt SD et al,. Activity wheel running reduces escape latency and alters brain monoamine levels after footshock. Brain Res Bull 1997 42 399-406 (Pubitemid 27161558)
30. Beck AT, Ward CH, Mendelson M et al,. An inventory for measuring depression. Arch Gen Psychiatry 1961 4 561-571
31. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale preliminary report. Psychopharmacol Bull 1973 9 13-28
32. Derogatis LR, Lipman RS, Rickels K et al,. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974 19 1-15
33. Dillon DJ, Gorman JM, Liebowitz MR et al,. Measurement of lactate-induced panic and anxiety. Psychiatry Res 1987 20 97-105 (Pubitemid 17033631)
34. Murphy DL, Mueller EA, Hill JL et al,. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology (Berl) 1989 98 275-282 (Pubitemid 19137745)
35. Kirschbaum C, Pirke KM, Hellhammer DH. The Trier social stress test a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993 28 76-81 (Pubitemid 23283755)
36. Morishima M, Harada N, Hara S et al,. Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats. Neuropsychopharmacology 2006 31 2627-2638 (Pubitemid 44764160)
37. Blumenthal JA, Fredrikson M, Kuhn CM et al,. Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia. Am J Cardiol 1990 65 93-98 (Pubitemid 20013930)
38. Summers H, Lustyk MK, Heitkemper M et al,. Effect of aerobic fitness on the physiological stress response in women. Biol Res Nurs 1999 1 48-56